166742-98-9 Usage
Uses
Used in Organic Synthesis:
(R)-benzyl methyl(1,2,3,4-tetrahydroquinolin-3-yl)carbamate is used as a building block for the synthesis of various bioactive compounds, leveraging its unique structural features and reactivity.
Used in Medicinal Chemistry:
(R)-benzyl methyl(1,2,3,4-tetrahydroquinolin-3-yl)carbamate is used as an intermediate in the development of pharmaceutical drugs, potentially contributing to the creation of new therapeutic agents.
Used in Pharmaceutical Drug Development:
(R)-benzyl methyl(1,2,3,4-tetrahydroquinolin-3-yl)carbamate is used as a precursor in the synthesis of drugs, due to its potential to form bioactive compounds with therapeutic properties.
Used in Agrochemical Development:
(R)-benzyl methyl(1,2,3,4-tetrahydroquinolin-3-yl)carbamate is used as a starting material in the creation of agrochemicals, potentially leading to the development of new pesticides or other agricultural products.
Note: The specific applications in different industries and the reasons for their use are not provided in the materials. The uses listed above are inferred based on the general properties and potential of the compound as described. Further research and studies would be required to confirm these applications and identify specific industries where the compound is utilized.
Check Digit Verification of cas no
The CAS Registry Mumber 166742-98-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,6,7,4 and 2 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 166742-98:
(8*1)+(7*6)+(6*6)+(5*7)+(4*4)+(3*2)+(2*9)+(1*8)=169
169 % 10 = 9
So 166742-98-9 is a valid CAS Registry Number.
166742-98-9Relevant articles and documents
Heterocyclic amines having central nervous system activity
-
, (2008/06/13)
Tricyclic nitrogen containing compounds, having anxiolytic and anti-depressant activity and central nervous system activity of the following structural formula: STR1 and pharmaceutically acceptable salts thereof wherein R1 and R2 are
Synthesis of the Selective D2 Receptor Agonist PNU-95666E from D-Phenylalanine Using a Sequential Oxidative Cyclization Strategy
Romero, Arthur G.,Darlington, William H.,McMillan, Moses W.
, p. 6582 - 6587 (2007/10/03)
Compound 1 (PNU-95666E) is a selective and high-affinity agonist at the dopamine D2 receptor subtype and is of interest as a potential agent for the treatment of Parkinson's disease. Requiring a synthetic route amenable to scale-up, a synthesis